TVRD
Tvardi Therapeutics
TVRD
TVRD
163 hedge funds and large institutions have $166M invested in Tvardi Therapeutics in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 37 increasing their positions, 58 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
36% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 58
53% less capital invested
Capital invested by funds: $354M → $166M (-$187M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
163
Holding in Top 10
–
Calls
$644K
Puts
$135K
Top Buyers
| 1 | +$1.86M | |
| 2 | +$961K | |
| 3 | +$905K | |
| 4 |
Two Sigma Investments
New York
|
+$804K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$655K |
Top Sellers
| 1 | -$2.41M | |
| 2 | -$2.1M | |
| 3 | -$1.73M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.09M |
| 5 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
-$1.08M |